Sufferers will be capable of entry Eli Lilly’s weight reduction drug Zepbound at Walmart pharmacies nationwide by its direct-to-consumer program as quickly as subsequent month.
The partnership between Eli Lilly and Firm and Walmart, introduced Wednesday, will permit folks with a legitimate prescription to select up single-dose vials of Zepbound at Walmart pharmacies nationwide or go for house supply.
Each are enabled by Eli Lilly’s direct-to-consumer platform, LillyDirect.
Lily’s direct-to-consumer platform, which launched in early 2024, is the corporate’s answer to enhance the affordability and availability of the blockbuster drug as a result of it permits some shoppers to purchase medicines immediately from Eli Lilly with out going by insurance coverage.
ELI LILLY CUTS COST OF CERTAIN ZEPBOUND DOSES BY AT LEAST 50%
The corporate mentioned LillyDirect gives financial savings of fifty% or extra in comparison with the listing value of comparable medicines for weight problems. With Eli Lilly’s direct-to-consumer platform, sufferers can entry the really helpful beginning dose of Zepbound for $349 monthly. The worth sits at $499 monthly for all different doses.
Nonetheless, to entry the upper doses, sufferers want to fulfill the necessities for the Zepbound Self Pay Journey Program, the corporate mentioned.
The partnership between Eli Lilly and Firm and Walmart, introduced Wednesday, will permit folks with a legitimate prescription to select up single-dose vials of Zepbound at Walmart pharmacies nationwide or go for house supply. (Patrick Fallon/Bloomberg through Getty Photos)
ELI LILLY’S ZEPBOUND REDUCES TYPE 2 DIABETES RISK, STUDY SHOWS
The drug has surged in reputation on account of its weight reduction results because it was accepted by the Meals and Drug Administration in 2023, however entry to it hasn’t all the time been straightforward on account of insurance coverage and protection points.
The drug has surged in reputation on account of its weight reduction results because it was accepted by the Meals and Drug Administration in 2023. (Reuters/Brendan McDermid)
The drug was accepted for power weight administration in adults with weight problems or chubby situations. It’s thought-about a GLP-1 agonist, a category of Sort 2 diabetes medication that improves blood sugar management however can also result in weight reduction. Semaglutide, the energetic ingredient in Novo Nordisk’s Wegovy and Ozempic, can also be thought-about a GLP-1 drug.
CVS CAREMARK DROPS COVERAGE OF POPULAR WEIGHT LOSS DRUG
Demand for the medication surged largely due to folks utilizing them off-label for weight reduction. (David Allio/Icon Sportswire through Getty Photos)
Even when sufferers have insurance coverage, corporations like Cigna typically require prior authorization for Zepbound and contain particular standards resembling BMI thresholds, comorbid situations and prior remedy makes an attempt.
Ticker Safety Final Change Change % WMT WALMART INC. 102.46 -0.71
-0.69%
GET FOX BUSINESS ON THE GO BY CLICKING HERE
Demand for the medication surged largely due to folks utilizing them off-label for weight reduction, leaving many sufferers who relied on them for accepted therapies struggling to get entry.
